Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study). (Q35601018)
Jump to navigation
Jump to search
scientific article published on 13 September 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study). |
scientific article published on 13 September 2011 |
Statements
1 reference
Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study). (English)
1 reference
Jeffrey Kaine
1 reference
Geoffrey Gladstein
1 reference
Ingrid Strusberg
1 reference
Manuel Robles
1 reference
Ingrid Louw
1 reference
Sheila Gujrathi
1 reference
Ramesh Pappu
1 reference
Ingrid Delaet
1 reference
Miranda Pans
1 reference
Charles Ludivico
1 reference
13 September 2011
1 reference
1 reference
71
1 reference
1
1 reference
38-44
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference